Search

Search Constraints

You searched for: Author/Creator Poi, Ming

Search Results

1. A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas. Issue 10 (3rd October 2017)

2. Factors Predicting Participation in the Prospective Genomic Sequencing Study, Total Cancer Care (TCC), in Kentucky. Issue 1 (6th July 2020)

3. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non‐Hodgkin's lymphoma. Issue 1 (30th September 2013)

4. G-CSF improves safety when you start the day after autologous transplant in multiple myeloma. Issue 12 (2nd December 2017)

5. Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study. (14th November 2019)

6. Pharmacokinetic‐Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High‐Dose Melphalan for Autologous Stem Cell Transplant. (20th October 2018)

7. The combination of milatuzumab, a humanized anti‐CD74 antibody, and veltuzumab, a humanized anti‐CD20 antibody, demonstrates activity in patients with relapsed and refractory B‐cell non‐Hodgkin lymphoma. (7th April 2015)